WallStSmart

Cognex Corporation (CGNX)vsVuzix Corp Cmn Stk (VUZI)

VS

Smart Verdict

WallStSmart Research — data-driven comparison

Cognex Corporation generates 17085% more annual revenue ($1.05B vs $6.09M). CGNX leads profitability with a 13.6% profit margin vs 0.0%. CGNX earns a higher WallStSmart Score of 58/100 (C).

CGNX

Buy

58

out of 100

Grade: C

Growth: 6.7Profit: 6.5Value: 4.7Quality: 9.0
Piotroski: 5/9Altman Z: 3.05

VUZI

Avoid

16

out of 100

Grade: F

Growth: 2.7Profit: 2.5Value: 6.7Quality: 7.0
Piotroski: 4/9Altman Z: -11.95
IV

Intrinsic Value Comparison

Multi-model valuation · Graham Formula

CGNXUndervalued (+48.5%)

Margin of Safety

+48.5%

Fair Value

$83.47

Current Price

$60.82

$22.65 discount

UndervaluedFair: $83.47Overvalued
VUZIUndervalued (+40.5%)

Margin of Safety

+40.5%

Fair Value

$4.15

Current Price

$4.23

$0.08 discount

UndervaluedFair: $4.15Overvalued

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

CGNX5 strengths · Avg: 9.2/10
EPS GrowthGrowth
122.3%10/10

Earnings expanding 122.3% YoY

Debt/EquityHealth
0.0510/10

Conservative balance sheet, low leverage

Altman Z-ScoreHealth
3.0510/10

Safe zone — low bankruptcy risk

Operating MarginProfitability
22.3%8/10

Strong operational efficiency at 22.3%

Revenue GrowthGrowth
24.3%8/10

Revenue surging 24.3% year-over-year

VUZI1 strengths · Avg: 10.0/10
Debt/EquityHealth
0.0310/10

Conservative balance sheet, low leverage

Areas to Watch

CGNX2 concerns · Avg: 2.0/10
PEG RatioValuation
2.712/10

Expensive relative to growth rate

P/E RatioValuation
74.8x2/10

Premium valuation, high expectations priced in

VUZI4 concerns · Avg: 3.5/10
Price/BookValuation
14.1x4/10

Trading at 14.1x book value

EPS GrowthGrowth
0.0%4/10

0.0% earnings growth

Market CapQuality
$259.45M3/10

Smaller company, higher risk/reward

Profit MarginProfitability
0.0%3/10

0.0% margin — thin

Comparative Analysis Report

WallStSmart Research

Bull Case : CGNX

The strongest argument for CGNX centers on EPS Growth, Debt/Equity, Altman Z-Score. Revenue growth of 24.3% demonstrates continued momentum.

Bull Case : VUZI

The strongest argument for VUZI centers on Debt/Equity.

Bear Case : CGNX

The primary concerns for CGNX are PEG Ratio, P/E Ratio. A P/E of 74.8x leaves little room for execution misses.

Bear Case : VUZI

The primary concerns for VUZI are Price/Book, EPS Growth, Market Cap.

Key Dynamics to Monitor

CGNX profiles as a growth stock while VUZI is a value play — different risk/reward profiles.

VUZI carries more volatility with a beta of 1.69 — expect wider price swings.

CGNX is growing revenue faster at 24.3% — sustainability is the question.

CGNX generates stronger free cash flow (42M), providing more financial flexibility.

Bottom Line

CGNX scores higher overall (58/100 vs 16/100) and 24.3% revenue growth. VUZI offers better value entry with a 40.5% margin of safety. Both earn "Buy" and "Avoid" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

Cognex Corporation

TECHNOLOGY · SCIENTIFIC & TECHNICAL INSTRUMENTS · USA

Cognex Corporation offers machine vision products that capture and analyze visual information to automate manufacturing and distribution tasks globally. The company is headquartered in Natick, Massachusetts.

Visit Website →

Vuzix Corp Cmn Stk

TECHNOLOGY · CONSUMER ELECTRONICS · USA

Vuzix Corporation designs, manufactures, markets and sells augmented reality (AR) computing and display devices for consumer and business markets in North America, Asia-Pacific, Europe, and internationally. The company is headquartered in West Henrietta, New York.

Want to dig deeper into these stocks?